See how one artist turned a hundred comments into the spark for a large-scale art project. The video details the impact of community feedback on creative decisions, highlighting the role of dialogue ...

Background: Recurrent stroke burden exceeds 10% within the first year. Dual antiplatelet therapy (DAPT) is recommended for short-term secondary prevention after non-cardioembolic high-risk TIA or ...

I team up with Portix to create a large collaborative doodle artwork filled with hundreds of small drawings. The video shows the full process in time-lapse, from an empty surface to a detailed final ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Walter Koroshetz, director of the National Institute of Neurological Disorders and ...

GenAI models have reached a point where the line between real and synthetic imagery is almost indistinguishable. Systems such as Sora and Gemini Nano Banana can preserve individual characters across ...

Dec 3 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

A man in his seventies presented with a brief episode of vertical visual tilt after blinking, described as a room tilting to the right, together with rightward deviation when walking, mild vertigo, ...

Contrary to previous research, transgender women who use the hormone estradiol for their transition do not have an increased risk of heart attack and stroke compared to men in the general Dutch ...

CLINICAL QUESTION: Does an updated National Institutes of Health Stroke Scale (NIHSS) language assessment tool perform well in a sample of diverse, neurologically unimpaired English-speaking adults?

US-based biopharma Silver Creek Pharmaceuticals’ late intervention acute ischemic stroke candidate, SCP-776, has demonstrated varied results in a mid-stage trial. During the Phase II ARPEGGIO ...

Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset) – a population with no approved drug options. Scp776 was safe and ...

LOS ANGELES -- A course of transcranial direct current stimulation (tDCS) did not help with post-stroke motor recovery when tested in a larger multicenter randomized trial. Among stroke survivors 1-6 ...